Showing results (251-260 of 548) with videos related to

Sort By:
Pageof 55
Therapeutic Advances in Psychopharmacology|September 24, 2024
Incorporation of a specialist mental health clinical pharmacist within a primary care network: patient referrals, prescribing decisions, and clinical outcomesRebecca Henry, David S Baldwin
Therapeutic Advances in Psychopharmacology|March 9, 2026
Plain Language Summary of Publication: What experts agree about using long-acting injectable antipsychotic medicine for people early in their experience of schizophreniaAndrea Fagiolini, Murat Yildirim, Celso Arango, et al.
Therapeutic Advances in Psychopharmacology|March 5, 2026
The acute effects of Zensera™ (Melissa officinalis L.) extract on mood and cognitive performance during cognitive overload: a randomised placebo-controlled, double-blind study in healthy young adults with moderate subjective stressImogen Mathews, Jessica Eastwood, Lynne Bell, et al.
Therapeutic Advances in Psychopharmacology|October 17, 2024
Exploring the clinical factors affecting lithium dose and plasma level and the effect of brandCarol Paton, Paul Bassett, Olivia Rendora, et al.
Therapeutic Advances in Psychopharmacology|May 25, 2026
Corrigendum to "Intranasal esketamine in treatment-resistant depression: long-term dosing patterns and clinical outcomes in a 5-year observational study"
Therapeutic Advances in Psychopharmacology|February 24, 2026
The interplay between serotonin syndrome and syndrome of inappropriate antidiuresis: a fatal case of acute hyponatremia during treatment with duloxetine, chlorphenamine, amitriptyline, and L-tryptophanDonato Morena, Salvatore Silvio Colonna, Alessandro Santurro, et al.
Therapeutic Advances in Psychopharmacology|July 27, 2026
Conceptual analysis of mechanisms and methods in psychedelic clinical trial design: a narrative reviewMartin Krsak, David Sparrow, Bernard Rosner, et al.
Therapeutic Advances in Psychopharmacology|July 6, 2026
Assessment of clozapine taste in healthy volunteers: evidence for non-aversive sensory profileLaura Modica de Mohac, Alex Keeley, David Taylor, et al.
Therapeutic Advances in Psychopharmacology|January 8, 2020
6-Sulfatoxymelatonin predicts treatment response to fluoxetine in major depressive disorderJuliana Jury Freitas, Nicóli Bertuol Xavier, André Comiran Tonon, et al.
Therapeutic Advances in Psychopharmacology|April 17, 2026
Clozapine-related neutropenia and agranulocytosis in Korea: 2025 update for rethinking the role of monitoring systemNuree Kang, Ji Seon Jang, Sung Woo Joo, et al.
Pageof 55